Safety and Effectiveness of Nintedanib in Korean Patients

A Regulatory Required Non-interventional Study to Monitor the Safety and Effectiveness of Ofev(Nintedanib 150mg/100mg BID) in Korean Patients

The objectives of this study are to monitor the safety and effectiveness of Ofev in Korean patients in a routine clinical practice setting.

Inclusion Criteria:

• Patients who have been started on Ofev in accordance with the approved label in Korea
• Patients who have signed on the data release consent form

Exclusion Criteria:

• Patients for whom nintedanib is contraindicated according local label of Ofev

  • Patients with known hypersensitivity to Ofev, peanut or soya, or to any of the excipients
  • Women who are pregnant or nursing
  • Patients with moderate(Child pugh B) and severe(Child Pugh c) hepatic impairment